AAAAAA

   
Results: 1-14 |
Results: 14
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial
Authors: Batchelor, WB Mahaffey, KW Berger, PB Deutsch, E Meier, S Hasselblad, V Fry, ET Teirstein, PS Ross, AM Binanay, CA Zidar, JP
Citation: Wb. Batchelor et al., A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial, J AM COL C, 38(6), 2001, pp. 1608-1613
Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion
Authors: Roe, MT Ohman, EM Maas, ACP Christenson, RH Mahaffey, KW Granger, CB Harrington, RA Califf, RM Krucoff, MW
Citation: Mt. Roe et al., Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion, J AM COL C, 37(1), 2001, pp. 9-18
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial
Authors: Al-Khatib, SM Pieper, KS Lee, KL Mahaffey, KW Hochman, JS Pepine, CJ Kopecky, SL Akkerhuis, M Stepinska, J Simoons, ML Topol, EJ Califf, RM Harrington, RA
Citation: Sm. Al-khatib et al., Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial, AM J CARD, 88(1), 2001, pp. 76-79
Cardiac enzyme elevations after cardiac surgery: The cardiologist's perspective
Authors: Mahaffey, KW Alpert, JS
Citation: Kw. Mahaffey et Js. Alpert, Cardiac enzyme elevations after cardiac surgery: The cardiologist's perspective, AM HEART J, 141(3), 2001, pp. 321-324
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT
Authors: Akkerhuis, KM Deckers, JW Boersma, E Harrington, RA Stepinska, J Mahaffey, KW Wilcox, RG Lincoff, AM Keltai, M Topol, EJ Califf, RM Simoons, ML
Citation: Km. Akkerhuis et al., Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT, EUR HEART J, 21(5), 2000, pp. 371-381
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
Authors: Tcheng, JE O'Shea, JC Cohen, EA Pacchiana, CM Kitt, MM Lorenz, TJ Greenberg, S Strony, J Califf, RM Buller, C Cantor, WJ Joseph, DM Kitt, MM Lincoff, AM Madan, M Popma, J Teirstein, P Cohen, E Balleza, L Parsons, P Lui, H Young, J Fox, R Labinaz, M Jelley, J Williams, J Cohen, D Trovato, M Smith, J Henry, P Chisholm, R O'Donnell, D Talley, JD Pacheco, R Timmis, S Muraka, A Mann, T Cubeddu, G Tannenbaum, M Greene, J Santoian, E Wash, M Sheldon, S Pronesti, L Jain, A Alonzo, M Seidelin, P Richards, J Lopez, M Dittenber, R Johnson, K Levine, G Maresh, K Ferrando, T Sarembock, I Snyder, L Kieval, J Herlan, L Miller, M Bembridge, D Nair, R Hickel, L Kiernan, F Murphy, D Cloutier, J Conn, E Beardsley, J Ritchie, M Cragen, D Jafar, MZ Counihan, P Rosenfelder, D Ducas, J Montebruno, L Carere, R Radons, B Williams, L Owens, W Dougal, R Feldman, R Audrain, D Karamali, A Smith, M Blankenship, J Demko, SL Thompson, M Gacoich, G Chiodo, V Noll, P Ledley, G Miller, C Felten, W Garner, B Chandler, AB Easler, P Albin, G Page, A Maddox, W Allen, S Gilchrist, I Moore, R Zimmerman, H Curtis, M Hildebrand, K Greene, R Healy, E Meengs, W Carson, D George, J Roncevich, T Aharonian, V Browning, R Kostuk, W Carr, S Feit, F Gostomsky, B Butman, S Hannah, E Hassel, CD Hartley, D Shook, T Hiller-Mullin, S Brill, D Dillion, M Armstrong, B Kerns, D Pichard, A Okubagzi, P Nasser, T Driver, L Garrett, J Boltey, L Stouffer, G Potter, M Amidon, T Eggert, S Taussig, A Potter, K Natarajan, M Tartaglia, C Werner, J Dunlap, T Harrold-Runge, P Davidson, C Goodreau, L Herzog, W Calamunci, N Slater, A Tormey, D Phillips, W White, D Sridhar, K White, J Goodman, D Buchbinder, M Nasser, V Rapeport, K Vorman, P Weiner, B Borbone, M Shadoff, N Paap, C Rehman, A Haag, E Burchenal, J Kioussopoulos, K Senior, D Senior, J Piana, R Kirshenbaum, J Chan, S Chowdry, A Kraft, P Clark, V Fox, M Deutsch, E Shannon, T Quesada, R Brotherton, J Murrin, C Cinderella, J Hearne, S Seefried, V Farah, T Pakstis, D Bartolet, B Bond, C Debarardinis, C Montory, D Smith, G Gray, D Phillips, P Hathaway, S Manoukian, S Patrick, C Yakubov, S Brooks, J Block, P Block, B Muhlestein, JB Kim, S Shalev, Y Schmidt, W Resar, J Citro, K Stine, R Zumbuhl, J Moreyra, A Kreiger, S Berger, P Cannon, CP Fisher, L Hasselblad, V Foster, A Joseph, D Madan, M McLendon, C Rund, M Tillery, N Wood, F Mahaffey, KW Irwin, C Kulick, D Johnson, N Chen, J Greenberg, S Hogeboom, C Lorenz, TJ Terifay, R Strony, J Veltri, E
Citation: Je. Tcheng et al., Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, LANCET, 356(9247), 2000, pp. 2037-2044
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation
Authors: Alexander, JH Sparapani, RA Mahaffey, KW Deckers, JW Newby, LK Ohman, EM Corbalan, R Chierchia, SL Boland, JB Simoons, ML Califf, RM Topol, EJ Harrington, RA
Citation: Jh. Alexander et al., Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation, J AM MED A, 283(3), 2000, pp. 347-353
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes
Authors: Mark, DB Harrington, RA Lincoff, AM Califf, RM Nelson, CL Tsiatis, AA Buell, H Mahaffey, KW Davidson-Ray, L Topol, EJ
Citation: Db. Mark et al., Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes, CIRCULATION, 101(4), 2000, pp. 366-371
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction - Results of a multicenter, randomized, placebo-controlled trial: TheAcute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial
Authors: Mahaffey, KW Puma, JA Barbagelata, NA DiCarli, MF Leesar, MA Browne, KF Eisenberg, PR Bolli, R Casas, AC Molina-Viamonte, V Orlandi, C Blevins, R Gibbons, RJ Califf, RM Granger, CB
Citation: Kw. Mahaffey et al., Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction - Results of a multicenter, randomized, placebo-controlled trial: TheAcute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial, J AM COL C, 34(6), 1999, pp. 1711-1720
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention
Authors: Tardiff, BE Califf, RM Tcheng, JE Lincoff, AM Sigmon, KN Harrington, RA Mahaffey, KW Ohman, EM Teirstein, PS Blankenship, JC Kitt, MM Topol, EJ
Citation: Be. Tardiff et al., Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention, J AM COL C, 33(1), 1999, pp. 88-96
The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: An AMISTAD substudy
Authors: Barbagelata, A Di Carli, MF Sgarbossa, EB Califf, RM Clemmensen, P Criger, DA Gates, KB Gibbons, RJ Casabe, H Granger, CB Wagner, GS Mahaffey, KW
Citation: A. Barbagelata et al., The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: An AMISTAD substudy, J ELCARDIOL, 32, 1999, pp. 111-113
Effects of stroke on medical resource use and costs in acute myocardial infarction
Authors: Tung, CY Granger, CB Sloan, MA Topol, EJ Knight, JD Weaver, WD Mahaffey, KW White, H Clapp-Channing, N Simoons, ML Gore, JM Califf, RM Mark, DB
Citation: Cy. Tung et al., Effects of stroke on medical resource use and costs in acute myocardial infarction, CIRCULATION, 99(3), 1999, pp. 370-376
Stroke in patients with acute coronary syndromes - Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial
Authors: Mahaffey, KW Harrington, RA Simoons, ML Granger, CB Graffagnino, C Alberts, MJ Laskowitz, DT Miller, JM Sloan, MA Berdan, LG MacAulay, CM Lincoff, AM Deckers, J Topol, EJ Califf, RM
Citation: Kw. Mahaffey et al., Stroke in patients with acute coronary syndromes - Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 99(18), 1999, pp. 2371-2377
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial
Authors: Mahaffey, KW Granger, CB Sloan, MA Green, CL Gore, JM Weaver, WD White, HD Simoons, ML Barbash, GI Topol, EJ Califf, RM
Citation: Kw. Mahaffey et al., Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial, AM HEART J, 138(3), 1999, pp. 493-499
Risultati: 1-14 |